Cargando…

Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure

The key biological “drivers” that are responsible for reverse left ventricle (LV) remodeling are not well understood. To gain an understanding of the role of the autophagy-lysosome pathway in reverse LV remodeling, we used a pathophysiologically relevant murine model of reversible heart failure, whe...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Sarah, Ma, Xiucui, Wang, Xiqiang, Chen, Yana, Zhao, Chen, Weinheimer, Carla J., Kovacs, Attila, Finck, Brian, Diwan, Abhinav, Mann, Douglas L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831862/
https://www.ncbi.nlm.nih.gov/pubmed/36644282
http://dx.doi.org/10.1016/j.jacbts.2022.06.003
_version_ 1784867938309767168
author Evans, Sarah
Ma, Xiucui
Wang, Xiqiang
Chen, Yana
Zhao, Chen
Weinheimer, Carla J.
Kovacs, Attila
Finck, Brian
Diwan, Abhinav
Mann, Douglas L.
author_facet Evans, Sarah
Ma, Xiucui
Wang, Xiqiang
Chen, Yana
Zhao, Chen
Weinheimer, Carla J.
Kovacs, Attila
Finck, Brian
Diwan, Abhinav
Mann, Douglas L.
author_sort Evans, Sarah
collection PubMed
description The key biological “drivers” that are responsible for reverse left ventricle (LV) remodeling are not well understood. To gain an understanding of the role of the autophagy-lysosome pathway in reverse LV remodeling, we used a pathophysiologically relevant murine model of reversible heart failure, wherein pressure overload by transaortic constriction superimposed on acute coronary artery (myocardial infarction) ligation leads to a heart failure phenotype that is reversible by hemodynamic unloading. Here we show transaortic constriction + myocardial infarction leads to decreased flux through the autophagy-lysosome pathway with the accumulation of damaged proteins and organelles in cardiac myocytes, whereas hemodynamic unloading is associated with restoration of autophagic flux to normal levels with incomplete removal of damaged proteins and organelles in myocytes and reverse LV remodeling, suggesting that restoration of flux is insufficient to completely restore myocardial proteostasis. Enhancing autophagic flux with adeno-associated virus 9–transcription factor EB resulted in more favorable reverse LV remodeling in mice that had undergone hemodynamic unloading, whereas overexpressing transcription factor EB in mice that have not undergone hemodynamic unloading leads to increased mortality, suggesting that the therapeutic outcomes of enhancing autophagic flux will depend on the conditions in which flux is being studied.
format Online
Article
Text
id pubmed-9831862
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98318622023-01-12 Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure Evans, Sarah Ma, Xiucui Wang, Xiqiang Chen, Yana Zhao, Chen Weinheimer, Carla J. Kovacs, Attila Finck, Brian Diwan, Abhinav Mann, Douglas L. JACC Basic Transl Sci Original Research - Preclinical The key biological “drivers” that are responsible for reverse left ventricle (LV) remodeling are not well understood. To gain an understanding of the role of the autophagy-lysosome pathway in reverse LV remodeling, we used a pathophysiologically relevant murine model of reversible heart failure, wherein pressure overload by transaortic constriction superimposed on acute coronary artery (myocardial infarction) ligation leads to a heart failure phenotype that is reversible by hemodynamic unloading. Here we show transaortic constriction + myocardial infarction leads to decreased flux through the autophagy-lysosome pathway with the accumulation of damaged proteins and organelles in cardiac myocytes, whereas hemodynamic unloading is associated with restoration of autophagic flux to normal levels with incomplete removal of damaged proteins and organelles in myocytes and reverse LV remodeling, suggesting that restoration of flux is insufficient to completely restore myocardial proteostasis. Enhancing autophagic flux with adeno-associated virus 9–transcription factor EB resulted in more favorable reverse LV remodeling in mice that had undergone hemodynamic unloading, whereas overexpressing transcription factor EB in mice that have not undergone hemodynamic unloading leads to increased mortality, suggesting that the therapeutic outcomes of enhancing autophagic flux will depend on the conditions in which flux is being studied. Elsevier 2022-10-19 /pmc/articles/PMC9831862/ /pubmed/36644282 http://dx.doi.org/10.1016/j.jacbts.2022.06.003 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research - Preclinical
Evans, Sarah
Ma, Xiucui
Wang, Xiqiang
Chen, Yana
Zhao, Chen
Weinheimer, Carla J.
Kovacs, Attila
Finck, Brian
Diwan, Abhinav
Mann, Douglas L.
Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure
title Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure
title_full Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure
title_fullStr Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure
title_full_unstemmed Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure
title_short Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure
title_sort targeting the autophagy-lysosome pathway in a pathophysiologically relevant murine model of reversible heart failure
topic Original Research - Preclinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831862/
https://www.ncbi.nlm.nih.gov/pubmed/36644282
http://dx.doi.org/10.1016/j.jacbts.2022.06.003
work_keys_str_mv AT evanssarah targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure
AT maxiucui targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure
AT wangxiqiang targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure
AT chenyana targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure
AT zhaochen targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure
AT weinheimercarlaj targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure
AT kovacsattila targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure
AT finckbrian targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure
AT diwanabhinav targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure
AT manndouglasl targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure